Controlled Substances Market Size, Trends, Growth & Outlook

Controlled Substances Market - By Drug Class (Opioids, Stimulants, Depressants, Others), By Distribution Channel (Hospitals, Clinics, Rehabilitation Centers, Retail Pharmacies, Online), By Application (Pain Management, Attention-Deficit, Depression, Seizure, Anxiety, Sleep Disorders, Others) & Global Region - Market Size, Trends, Opportunity, Forecast 2019 - 2027

Industry: Life Science | Report ID: FAMI-00672 | Published on: Nov, 2019 | View: 1817 | Share:         

Request Sample Enquire Before Buying Request Discount

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

  • Report Descripton
  • Table Of Content
  • Request Methodology
  • Request Customization

Facto Market Insights added a title on “Controlled Substances Market – 2019 - 2027” to its collection of industry research reports. The Controlled Substances Market research report represents the analysis of all the segments, which includes the market size, Y-O-Y growth analysis and structure of the overall industry based on a unique combination of industry research, fieldwork, market sizing analysis, and our in-house expertise.

The Controlled Substances Market research report demonstrates market dynamics, which includes growth drivers, barriers, opportunities, and trends spearheading current nature and future status of this market. Facto Market Insights’ study also consists of the recent developments that are setting the level of competition in the Controlled Substances Market, along with accurate and complete information about the major & niche players in the market.

Moreover, Porter’s Five Forces analysis demonstrates the five forces which include buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in the Global Controlled Substances Market. Along with figures and tables, market attractiveness and BPS analysis have been provided for every segment in the report. In addition to this, the report offers recent industry activities and value chain analysis for the Controlled Substances Market.

Global Controlled Substances Market Segmentation  

The research offers a comprehensive analysis of global Controlled Substances Market with respect to following sub-markets:

Controlled Substances Market, by Drug Class:

  • Opioids
      • Morphine
      • Fentanyl
      • Codeine
      • Meperidine
      • Methadone
      • Oxycodone
      • Others
  • Stimulants
      • Methylphenidate
      • Dextroamphetamine
      • Amphetamine
      • Methamphetamine
      • Others
  • Depressants
      • Barbiturates
      • Benzodiazepines
  • Marijuana
      • Medical Marijuana
      • Recreational Marijuana

Controlled Substances Market, by Distribution Channel:

  • Hospitals
  • Clinics
  • Retail Pharmacies
  • Rehabilitation Centers
  • Online

Controlled Substances Market, by Application:

  • Pain Management
  • Depression
  • Attention-Deficit/Hyperactivity Disorder (ADHD)
  • Seizure
  • Anxiety           
  • Sleep Disorders
  • Cough Suppression
  • Others

Controlled Substances Market, By Region:

The report analyses the market by geographies i.e. North America, Europe, Asia Pacific, Latin America & Middle East & Africa. Further, the geographies are fragmented into the country and regional groupings:

- North America (U.S. & Canada)

- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)

- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)

- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)

- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Global Controlled Substances Market: Competitive Landscape

The report also highlights the competitive landscape of the global Controlled Substances Market, market share and positioning of all the major players in the industry. The competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as company overview, financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development and other market activities).

The report includes profiles of leading companies in the global Controlled Substances Market. Some of the key players profiled include:

  • Consort Medical
  • Cayman Chemical
  • Cambrex
  • Patheon
  • AMRI
  • Siegfried AG           
  • Johnson Matthey
  • SAFC/Cerilliant
  • Noramco, Inc
  • Mallinckrodt plc

Get a sample pages of this report Click here

Research Methodology

Market Definition and List of Abbreviations

1.    Executive Summary
2.    Growth Drivers & Issues in Global Controlled Substances Market
3.    Global Controlled Substances Market Trends
4.    Opportunities in Global Controlled Substances Market
5.    Recent Industry Activities, 2017
6.    Porter's Five Forces Analysis
7.    Market Value Chain and Supply Chain Analysis
8.    Global Controlled Substances Market Size (USD Million), Growth Analysis and Forecast, (2019 - 2027)

9.    Global Controlled Substances Market Segmentation Analysis, By Drug Class

9.1.    Introduction
9.2.    Market Attractiveness, By Drug Class
9.3.    BPS Analysis, By Drug Class
9.4.    Opioids
9.4.1.    Morphine
9.4.2.    Fentanyl
9.4.3.    Codeine
9.4.4.    Meperidine
9.4.5.    Methadone
9.4.6.    Oxycodone
9.4.7.    Others
9.5.    Stimulants
9.5.1.    Methylphenidate
9.5.2.    Extroamphetamine
9.5.3.    Dextroamphetamine
9.5.4.    Methamphetamine
9.5.5.    Others
9.6.    Depressants
9.6.1.    Barbiturates
9.6.2.    Benzodiazepines
9.7.    Marijuana
9.7.1.    Medical Marijuana
9.7.2.    Recreational Marijuana

10.     Global Controlled Substances Market Segmentation Analysis, By Distribution Channel Type

10.1.    Introduction
10.2.    Market Attractiveness, By Distribution Channel
10.3.    BPS Analysis, By Distribution Channel
10.4.    Hospitals
10.5.    Clinics
10.6.    Retail Pharmacies
10.7.    Rehabilitation Centers
10.8.    Online

11.    Global Controlled Substances Market Segmentation Analysis, By Application

11.1.    Introduction
11.2.    Market Attractiveness, By Application
11.3.    BPS Analysis, By Application
11.4.    Pain Management
11.5.    Depression
11.6.    Attention-Deficit/Hyperactivity Disorder (ADHD)
11.7.    Seizure
11.8.    Anxiety            
11.9.    Sleep Disorders
11.10.    Cough Suppression
11.11.    Others 

12.    Geographical Analysis

12.1.    Introduction
12.2.    North America Controlled Substances Market Size (USD Million), 2019 - 2027
12.2.1.    By Drug Class
12.2.2.    By Distribution Channel
12.2.3.    By Application
12.2.4.    By Country
12.2.4.1.    Market Attractiveness, By End-user
12.2.4.2.    BPS Analysis, By End-User
12.2.4.3.    U.S. Market Size (USD Million), 2019 - 2027
12.2.4.4.    Canada Market Size (USD Million), 2019 - 2027

12.3.    Europe Controlled Substances Market Size (USD Million), 2019 - 2027

12.3.1.    By Drug Class
12.3.2.    By Distribution Channel
12.3.3.    By Application
12.3.4.    By Country
12.3.4.1.    Market Attractiveness, By Country
12.3.4.2.    BPS Analysis, By Country
12.3.4.3.    Germany Market Size (USD Million), 2019 - 2027
12.3.4.4.    United Kingdom Market Size (USD Million), 2019 - 2027
12.3.4.5.    France Market Size (USD Million), 2019 - 2027
12.3.4.6.    Italy Market Size (USD Million), 2019 - 2027
12.3.4.7.    Spain Market Size (USD Million), 2019 - 2027
12.3.4.8.    Russia Market Size (USD Million), 2019 - 2027
12.3.4.9.    Rest of Europe Market Size (USD Million), 2019 - 2027

12.4.    Asia Pacific Controlled Substances Market Size (USD Million), 2019 - 2027

12.4.1.    By Drug Class
12.4.2.    By Distribution Channel
12.4.3.    By Application
12.4.4.    By Country
12.4.4.1.    Market Attractiveness, By Country
12.4.4.2.    BPS Analysis, By Country
12.4.4.3.    China Market Size (USD Million), 2019 - 2027
12.4.4.4.    India Market Size (USD Million), 2019 - 2027
12.4.4.5.    Japan Market Size (USD Million), 2019 - 2027
12.4.4.6.    South Korea Market Size (USD Million), 2019 - 2027
12.4.4.7.    Indonesia Market Size (USD Million), 2019 - 2027
12.4.4.8.    Taiwan Market Size (USD Million), 2019 - 2027
12.4.4.9.    Australia Market Size (USD Million), 2019 - 2027
12.4.4.10.    New Zealand Market Size (USD Million), 2019 - 2027
12.4.4.11.    Rest of Asia Pacific Market Size (USD Million), 2019 - 2027

12.5.    Latin America Controlled Substances Market Size (USD Million), 2019 - 2027

12.5.1.    By Drug Class
12.5.2.    By Distribution Channel
12.5.3.    By Application
12.5.4.    By Country
12.5.4.1.    Market Attractiveness, By Country
12.5.4.2.    BPS Analysis, By Country
12.5.4.3.    Brazil Market Size (USD Million), 2019 - 2027
12.5.4.4.    Mexico Market Size (USD Million), 2019 - 2027
12.5.4.5.    Rest of Latin America Market Size (USD Million), 2019 - 2027

12.6.    Middle East & Africa Controlled Substances Market Size (USD Million), 2019 - 2027

12.6.1.    By Drug Class
12.6.2.    By Distribution Channel
12.6.3.    By Application
12.6.4.    By Country
12.6.4.1.    Market Attractiveness, By Geography
12.6.4.2.    BPS Analysis, By Geography
12.6.4.3.    GCC Market Size (USD Million), 2019 - 2027
12.6.4.4.    North Africa Market Size (USD Million), 2019 - 2027
12.6.4.5.    South Africa Market Size (USD Million), 2019 - 2027
12.6.4.6.    Rest of Middle East & Africa Market Size (USD Million), 2019 – 2029

13.     Competitive Landscape

13.1.    Consort Medical
13.2.    Cayman Chemical
13.3.    Cambrex
13.4.    Patheon
13.5.    AMRI
13.6.    Siegfried AG            
13.7.    Johnson Matthey
13.8.    SAFC/Cerilliant
13.9.    Noramco, Inc
13.10.    Mallinckrodt plc

Select License Type
  • Single User License $3840 USD
  • Multi-User License $5370 USD
  • Corporate User License $6450 USD

Our Clients

  • +1 518-300-1215Mon-Fri, 24Hrs
  • [email protected]We reply within an hours
  • Albany,
    NY, USA.